Karpanen T - Search Results

1

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K. He Y, et al. Among authors: karpanen t. J Natl Cancer Inst. 2002 Jun 5;94(11):819-25. doi: 10.1093/jnci/94.11.819. J Natl Cancer Inst. 2002. PMID: 12048269

2

VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.

Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K, Härkönen PL. Mattila MM, et al. Among authors: karpanen t. Int J Cancer. 2002 Apr 20;98(6):946-51. doi: 10.1002/ijc.10283. Int J Cancer. 2002. PMID: 11948478

3

Role of lymphangiogenic factors in tumor metastasis.

He Y, Karpanen T, Alitalo K. He Y, et al. Among authors: karpanen t. Biochim Biophys Acta. 2004 Mar 4;1654(1):3-12. doi: 10.1016/j.bbcan.2003.07.003. Biochim Biophys Acta. 2004. PMID: 14984763 Review.

4

Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein.

Keskitalo S, Tammela T, Lyytikka J, Karpanen T, Jeltsch M, Markkanen J, Yla-Herttuala S, Alitalo K. Keskitalo S, et al. Among authors: karpanen t. Circ Res. 2007 May 25;100(10):1460-7. doi: 10.1161/01.RES.0000269042.58594.f6. Epub 2007 May 3. Circ Res. 2007. PMID: 17478734

5

Molecular biology and pathology of lymphangiogenesis.

Karpanen T, Alitalo K. Karpanen T, et al. Annu Rev Pathol. 2008;3:367-97. doi: 10.1146/annurev.pathmechdis.3.121806.151515. Annu Rev Pathol. 2008. PMID: 18039141 Review.

6

Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.

Nykänen AI, Sandelin H, Krebs R, Keränen MA, Tuuminen R, Kärpänen T, Wu Y, Pytowski B, Koskinen PK, Ylä-Herttuala S, Alitalo K, Lemström KB. Nykänen AI, et al. Among authors: karpanen t. Circulation. 2010 Mar 30;121(12):1413-22. doi: 10.1161/CIRCULATIONAHA.109.910703. Epub 2010 Mar 15. Circulation. 2010. PMID: 20231530

7

Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor.

Zheng W, Tammela T, Yamamoto M, Anisimov A, Holopainen T, Kaijalainen S, Karpanen T, Lehti K, Ylä-Herttuala S, Alitalo K. Zheng W, et al. Among authors: karpanen t. Blood. 2011 Jul 28;118(4):1154-62. doi: 10.1182/blood-2010-11-317800. Epub 2011 May 12. Blood. 2011. PMID: 21566091 Free article.

8

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.

Saaristo A, Karpanen T, Alitalo K. Saaristo A, et al. Among authors: karpanen t. Oncogene. 2000 Dec 11;19(53):6122-9. doi: 10.1038/sj.onc.1203969. Oncogene. 2000. PMID: 11156525 Review.

9

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

Mäkinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, Kauppinen R, Jackson DG, Kubo H, Nishikawa S, Ylä-Herttuala S, Alitalo K. Mäkinen T, et al. Among authors: karpanen t. Nat Med. 2001 Feb;7(2):199-205. doi: 10.1038/84651. Nat Med. 2001. PMID: 11175851

10

Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.

Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Ylä-Herttuala S, Jäättelä M, Alitalo K. Karpanen T, et al. Cancer Res. 2001 Mar 1;61(5):1786-90. Cancer Res. 2001. PMID: 11280723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters